Thyrotoxicosis, unspecified with thyrotoxic crisis or storm
ICD-10 E05.91 is a billable code used to indicate a diagnosis of thyrotoxicosis, unspecified with thyrotoxic crisis or storm.
Thyrotoxicosis refers to a condition resulting from excessive thyroid hormone levels in the body, leading to a hypermetabolic state. When this condition escalates into a thyrotoxic crisis or storm, it becomes a life-threatening emergency characterized by severe symptoms such as high fever, tachycardia, altered mental status, and gastrointestinal disturbances. The crisis can occur in patients with untreated hyperthyroidism or those with a history of thyroid disorders, particularly in the context of stressors like infection, surgery, or trauma. The diagnosis of thyrotoxicosis is often made through clinical evaluation and laboratory tests, including serum thyroid hormone levels (T3 and T4) and thyroid-stimulating hormone (TSH) levels. In cases of thyrotoxic crisis, immediate medical intervention is critical to stabilize the patient and prevent complications such as heart failure or arrhythmias. The unspecified nature of this code indicates that the specific etiology of the thyrotoxicosis is not documented, which can complicate treatment and management strategies.
Thorough documentation of thyroid function tests, clinical symptoms, and treatment plans.
Patients presenting with symptoms of hyperthyroidism, requiring management of thyrotoxicosis.
Endocrinologists must ensure that all relevant lab results and clinical findings are documented to support the diagnosis.
Immediate documentation of vital signs, clinical presentation, and interventions performed.
Patients presenting to the emergency department with signs of thyrotoxic crisis.
Emergency physicians must act quickly and document all actions taken to stabilize the patient.
When evaluating a patient for thyrotoxicosis.
Document the rationale for testing and results.
Endocrinologists should ensure comprehensive lab results are included.
Common causes include Graves' disease, toxic multinodular goiter, thyroiditis, and excessive intake of thyroid hormone medications.
Treatment typically involves beta-blockers for symptom control, antithyroid medications, and supportive care to stabilize the patient.
